chr15-40471848-T-C

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBP6

The NM_130468.4(CHST14):​c.635T>C​(p.Val212Ala) variant causes a missense change. The variant allele was found at a frequency of 0.000322 in 1,613,726 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00043 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00031 ( 1 hom. )

Consequence

CHST14
NM_130468.4 missense

Scores

3
13
3

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:4

Conservation

PhyloP100: 6.27

Publications

7 publications found
Variant links:
Genes affected
CHST14 (HGNC:24464): (carbohydrate sulfotransferase 14) This gene encodes a member of the HNK-1 family of sulfotransferases. The encoded protein transfers sulfate to the C-4 hydroxyl of N-acetylgalactosamine residues in dermatan sulfate. Mutations in this gene have been associated with adducted thumb-clubfoot syndrome.[provided by RefSeq, Mar 2010]
CHST14 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome, musculocontractural type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Ehlers-Danlos syndrome, musculocontractural type
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.086407065).
BP6
Variant 15-40471848-T-C is Benign according to our data. Variant chr15-40471848-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 373593.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHST14NM_130468.4 linkc.635T>C p.Val212Ala missense_variant Exon 1 of 1 ENST00000306243.7 NP_569735.1 Q8NCH0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHST14ENST00000306243.7 linkc.635T>C p.Val212Ala missense_variant Exon 1 of 1 6 NM_130468.4 ENSP00000307297.6 Q8NCH0
CHST14ENST00000559991.1 linkc.560T>C p.Val187Ala missense_variant Exon 2 of 2 5 ENSP00000453882.1 H0YN65
ENSG00000302612ENST00000788112.1 linkn.-43A>G upstream_gene_variant

Frequencies

GnomAD3 genomes
AF:
0.000427
AC:
65
AN:
152142
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00807
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000515
Gnomad OTH
AF:
0.000957
GnomAD2 exomes
AF:
0.000538
AC:
135
AN:
251156
AF XY:
0.000478
show subpopulations
Gnomad AFR exome
AF:
0.0000618
Gnomad AMR exome
AF:
0.0000578
Gnomad ASJ exome
AF:
0.00725
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000493
Gnomad OTH exome
AF:
0.000489
GnomAD4 exome
AF:
0.000311
AC:
455
AN:
1461584
Hom.:
1
Cov.:
32
AF XY:
0.000347
AC XY:
252
AN XY:
727092
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.0000447
AC:
2
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00593
AC:
155
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53116
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.000246
AC:
274
AN:
1112010
Other (OTH)
AF:
0.000397
AC:
24
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
41
82
124
165
206
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000427
AC:
65
AN:
152142
Hom.:
1
Cov.:
32
AF XY:
0.000350
AC XY:
26
AN XY:
74332
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41434
American (AMR)
AF:
0.00
AC:
0
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00807
AC:
28
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000515
AC:
35
AN:
68014
Other (OTH)
AF:
0.000957
AC:
2
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.518
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000729
Hom.:
0
Bravo
AF:
0.000378
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00163
AC:
14
ExAC
AF:
0.000519
AC:
63
EpiCase
AF:
0.000164
EpiControl
AF:
0.000356

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:1
Jan 22, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: CHST14 c.635T>C (p.Val212Ala) results in a non-conservative amino acid change located in the Sulfotransferase family (IPR005331) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00032 in 1613726 control chromosomes, predominantly at a frequency of 0.0062 within the Ashkenazi Jewish subpopulation in the gnomAD database (v4), including 2 homozygotes. The observed variant frequency within Ashkenazi Jewish control individuals in the gnomAD database is approximately 5.55 fold of the estimated maximal expected allele frequency for a pathogenic variant in CHST14 causing Ehlers-Danlos syndrome, musculocontractural type phenotype (0.0011). To our knowledge, no occurrence of c.635T>C in individuals affected with Ehlers-Danlos syndrome, musculocontractural type and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 373593). Based on the evidence outlined above, the variant was classified as benign. -

Nov 29, 2016
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

A variant of uncertain significance has been identified in the CHST14 gene. The V212A variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The V212A substitution occurs at a position that is conserved through mammals, and alanine (A) is not wild type in any species. In addition, in silico analysis predicts this variant is probably damaging to the protein structure/function. Nonetheless, V212A is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. Finally, this variant has been reported in approximately 0.1-0.2% of alleles from individuals of European ancestry in the NHLBI Exome Sequencing Project and the Exome Aggregation Consortium (ExAC), including three homozygous individuals. -

Ehlers-Danlos syndrome Uncertain:1
Mar 01, 2020
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Nov 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CHST14: PP3, BS2 -

Ehlers-Danlos syndrome, musculocontractural type Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
May 09, 2022
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.50
BayesDel_addAF
Uncertain
0.15
D
BayesDel_noAF
Pathogenic
0.32
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.71
D;.
Eigen
Uncertain
0.62
Eigen_PC
Uncertain
0.56
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Benign
0.84
T;T
M_CAP
Uncertain
0.097
D
MetaRNN
Benign
0.086
T;T
MetaSVM
Uncertain
0.20
D
MutationAssessor
Uncertain
2.4
M;.
PhyloP100
6.3
PrimateAI
Pathogenic
0.82
D
PROVEAN
Uncertain
-3.7
D;D
REVEL
Pathogenic
0.75
Sift
Uncertain
0.0030
D;D
Sift4G
Uncertain
0.0090
D;T
Polyphen
1.0
D;.
Vest4
0.87
MVP
0.92
MPC
2.2
ClinPred
0.17
T
GERP RS
4.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.58
gMVP
0.69
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144629123; hg19: chr15-40764047; API